Cryoport (CYRX) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Cryoport Revenue Highlights


Latest Revenue (Y)

$233.25M

Latest Revenue (Q)

$56.66M

Main Segment (Y)

Biopharmaceutical

Main Geography (Y)

Americas

Cryoport Revenue by Period


Cryoport Revenue by Year

DateRevenueChange
2023-12-31$233.25M-1.70%
2022-12-31$237.28M6.59%
2021-12-31$222.61M182.87%
2020-12-31$78.70M131.86%
2019-12-31$33.94M72.94%
2018-12-31$19.63M64.18%
2017-12-31$11.95M55.68%
2016-12-31$7.68M95.13%
2015-03-31$3.94M47.95%
2014-03-31$2.66M141.69%
2013-03-31$1.10M98.07%
2012-03-31$555.64K16.85%
2011-03-31$475.50K303.12%
2010-03-31$117.96K235.83%
2009-03-31$35.12K-57.97%
2008-03-31$83.56K24.53%
2007-03-31$67.10K-55.94%
2006-03-31$152.30K-43.89%
2005-03-31$271.43K-

Cryoport generated $233.25M in revenue during NA 2022, up -1.70% compared to the previous quarter, and up 1188.47% compared to the same period a year ago.

Cryoport Revenue by Quarter

DateRevenueChange
2024-09-30$56.66M-1.62%
2024-06-30$57.60M5.50%
2024-03-31$54.59M-4.66%
2023-12-31$57.26M1.96%
2023-09-30$56.16M-1.52%
2023-06-30$57.02M-9.23%
2023-03-31$62.82M4.07%
2022-12-31$60.36M-0.18%
2022-09-30$60.46M-5.75%
2022-06-30$64.15M22.66%
2022-03-31$52.30M-7.33%
2021-12-31$56.44M-0.45%
2021-09-30$56.69M0.89%
2021-06-30$56.19M5.46%
2021-03-31$53.28M10.18%
2020-12-31$48.36M332.87%
2020-09-30$11.17M18.99%
2020-06-30$9.39M-3.94%
2020-03-31$9.77M5.76%
2019-12-31$9.24M-3.56%
2019-09-30$9.58M13.23%
2019-06-30$8.46M27.22%
2019-03-31$6.65M16.90%
2018-12-31$5.69M7.67%
2018-09-30$5.29M14.23%
2018-06-30$4.63M15.01%
2018-03-31$4.02M21.11%
2017-12-31$3.32M10.64%
2017-09-30$3.00M2.92%
2017-06-30$2.92M7.56%
2017-03-31$2.71M21.69%
2016-12-31$2.23M12.75%
2016-09-30$1.98M3.09%
2016-06-30$1.92M23.27%
2016-03-31$1.56M59.51%
2014-12-31$975.19K18.20%
2014-09-30$825.00K-11.91%
2014-06-30$936.59K12.19%
2014-03-31$834.83K10.23%
2013-12-31$757.33K30.61%
2013-09-30$579.83K18.83%
2013-06-30$487.96K32.42%
2013-03-31$368.49K19.97%
2012-12-31$307.15K31.49%
2012-09-30$233.60K22.11%
2012-06-30$191.30K8.13%
2012-03-31$176.92K22.64%
2011-12-31$144.25K30.30%
2011-09-30$110.71K-10.54%
2011-06-30$123.75K23.67%
2011-03-31$100.07K0.50%
2010-12-31$99.57K-19.97%
2010-09-30$124.41K-17.86%
2010-06-30$151.46K101.76%
2010-03-31$75.07K262.52%
2009-12-31$20.71K144.24%
2009-09-30$8.48K-38.13%
2009-06-30$13.70K110.46%
2009-03-31$6.51K-29.28%
2008-12-31$9.21K53.91%
2008-09-30$5.98K-55.44%
2008-06-27$13.42K-62.61%
2008-03-31$35.90K-

Cryoport generated $56.66M in revenue during Q3 2023, up -1.62% compared to the previous quarter, and up 99.37% compared to the same period a year ago.

Cryoport Revenue Breakdown


Cryoport Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Biopharmaceutical$192.58M----
Animal Health$30.38M----
Reproductive Medicine$10.29M----
Service-$133.88M$119.06M$55.30M-
Product-$103.40M$103.54M$23.40M-
Global Biostorage----$3.03M

Cryoport's latest annual revenue breakdown by segment (product or service), as of Dec 23: Biopharmaceutical (82.56%), Animal Health (13.02%), and Reproductive Medicine (4.41%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Product$17.39M$17.81M$27.27M$27.17M$29.57M$19.39M$24.72M$25.79M$26.51M$26.52M----------
Service$39.28M$36.79M$33.09M$33.30M$34.59M$32.91M$31.72M$30.90M$29.68M$26.77M----------
Biopharmaceutical--$94.93M$46.53M$51.12M---------------
Animal Health--$13.64M$7.87M$8.86M---------------
Reproductive Medicine--$4.85M$2.62M$2.83M---------------
Global Logistics Solutions-------------$52.27M$9.82M-----
Global Bioservices--------------$1.35M-----
Global Biostorage---------------$1.29M$1.27M$1.28M$1.17M$577.00K

Cryoport's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Service (69.32%), and Product (30.68%).

Cryoport Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
Europe, the Middle East and Africa (EMEA)$60.88M$42.16M$59.33M--
Americas$127.21M$128.21M$120.27M$49.55M$28.80M
Asia Pacific (APAC)$45.16M$66.91M$43.00M--
E M E A---$20.32M$4.52M
Asia Pacific---$8.82M$618.00K

Cryoport's latest annual revenue breakdown by geography, as of Dec 23: Americas (54.54%), Europe, the Middle East and Africa (EMEA) (26.10%), and Asia Pacific (APAC) (19.36%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Americas$30.77M$29.90M$62.43M$31.16M$33.62M$31.23M$34.21M$34.89M$27.88M$33.09M$30.31M$29.14M$27.73M$25.72M$8.75M$7.40M$7.68M$7.39M$7.71M$7.54M
Asia Pacific$11.42M$12.01M$11.34M$8.03M$413.00K$223.00K$157.00K$117.00K$176.00K$204.00K----------
EMEA$14.47M-------------------
Asia Pacific (APAC)-$9.08M$23.37M$10.74M$11.04M$36.02M$10.25M$12.41M$8.24M$7.64M$12.00M---------
Europe, the Middle East and Africa (EMEA)-$15.61M$27.61M$15.11M$18.16M$-6.89M$16.00M$16.85M$16.19M$15.70M$14.38M---------
E M E A-----------$15.04M$14.21M$14.61M$2.01M$1.76M$1.93M$1.74M$1.70M$724.00K

Cryoport's latest quarterly revenue breakdown by geography, as of Sep 24: Americas (54.31%), EMEA (25.54%), and Asia Pacific (20.15%).

Cryoport Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
NTRANatera$1.08B$439.76M
IRTCiRhythm$492.68M$147.54M
AXNXAxonics$366.38M$116.19M
CDNACareDx$280.32M$82.88M
CYRXCryoport$233.25M$56.66M
BLFSBioLife Solutions$143.27M$30.57M

CYRX Revenue FAQ


What is Cryoport’s yearly revenue?

Cryoport's yearly revenue for 2022 was $233.26M, representing a decrease of -1.70% compared to 2021. The company's yearly revenue for 2021 was $237.28M, representing an increase of 6.59% compared to 2020. CYRX's yearly revenue for 2020 was $222.61M, representing an increase of 182.87% compared to 2019.

What is Cryoport’s quarterly revenue?

Cryoport's quarterly revenue for Q3 2023 was $56.66M, a -1.62% decrease from the previous quarter (Q2 2023), and a 0.90% increase year-over-year (Q3 2022). The company's quarterly revenue for Q2 2023 was $57.6M, a 5.50% increase from the previous quarter (Q1 2023), and a 1.01% increase year-over-year (Q2 2022). CYRX's quarterly revenue for Q1 2023 was $54.59M, a -4.66% decrease from the previous quarter (Q4 2022), and a -13.09% decrease year-over-year (Q1 2022).

What is Cryoport’s revenue growth rate?

Cryoport's revenue growth rate for the last 3 years (2020-2022) was 4.78%, and for the last 5 years (2018-2022) was 587.22%.

What are Cryoport’s revenue streams?

Cryoport's revenue streams in c 23 are Biopharmaceutical, Animal Health, and Reproductive Medicine. Biopharmaceutical generated $192.58M in revenue, accounting 82.56% of the company's total revenue Animal Health generated $30.38M in revenue, accounting 13.02% of the company's total revenue Reproductive Medicine generated $10.29M in revenue, accounting 4.41% of the company's total revenue

What is Cryoport’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Cryoport was Biopharmaceutical. This segment made a revenue of $192.58M, representing 82.56% of the company's total revenue.